PMMPP2-Preparing to Prescribe for Nurses and Allied Health Professionals

Module Provider: Pharmacy
Number of credits: 20 [10 ECTS credits]
Level:7
Terms in which taught: Autumn / Spring term module
Pre-requisites:
Non-modular pre-requisites: Applicants must meet the NMC or HCPC entry criteria for enrolment on this module and demonstrate the ability to study at level 7.
Co-requisites:
Modules excluded: PM4PP2 Preparing to Prescribe for Nurses (level 6)
Current from: 2023/4

Module Convenor: Mrs Jan Glaze
Email: j.e.glaze@reading.ac.uk

Type of module:

Summary module description:

This module enables nurses and allied health professionals to practise and develop as prescribers and to begin meeting the standards set by the Nursing and Midwifery Council (NMC) or Health and Care Professions Council (HCPC), which after completion of PMMNP2, PMMAS1 or PMMAP2 will enable them to apply for annotation to the register to practise as prescribers.

The module can be studied as part of the Postgraduate Certificate in Independent Prescribing or as part of the MSc in Advancing Healthcare Practice.Ìý Practitioners will be supported to reflect on their experiences by developing a professional portfolio of their learning which is mapped to the Royal Pharmaceutical Society Competency Framework for all Prescribers.

Aims:

To enable nurses and allied health professions to develop the core competencies required to prepare them to study for module PMMNP2, PMMAS1 or PMMAP2.Ìý To demonstrate critical appraisal skills commensurate with Master’s level study.

Assessable learning outcomes:

The following learning outcomes are based on the programme requirements set by the HCPC and NMC for prescribing programmes.Ìý

°­²Ô´Ç·É±ô±ð»å²µ±ðÌý

1. Discuss the use of information sources, and the role of advice and decision support in prescribing practiceÌý


2. Explain the way medicines work in relation to the disease process (pharmacodynamics and pharmacokinetics)Ìý


3. Discuss how medicines are licensed and monitoredÌý


4. Describe the roles and relationships of others involved in prescribing, supplying and administering medicinesÌý


5. Discuss the unique implications and developmental context of the anatomical and physiological differences between neonates, children and young peopleÌý


6. Describe how consultation models can support appropriate communication with patientsÌý


7. Explain the pathophysiology of the disease state(s) within the stated scope of practiceÌý

³§°ì¾±±ô±ô²õÌý

1. Demonstrate the ability to analyse and apply knowledge of drug actions in prescribing practiceÌý


2. Demonstrate the ability to analyse and apply evidence-based medicine (EBM) to individualise patient careÌý


3. Demonstrate critical insight when analysing information, including a range of relevant primary sourcesÌý


4. Demonstrate a robust analysis of evidence, integrating theory and practice to formulate a justified argumentÌý


5. Provide, where relevant, evidence of study beyond the standard materialÌý

Ìý

Behaviours

1. Continually advance own knowledge, skills and behaviours through continuing professional development and life-long learningÌý


2. Demonstrate a systematic approach to medicines optimisation for patients within stated scope of practiceÌý


3. Demonstrate professional behaviours consistent with The Code (NMC) or Standards of conduct, performance and ethics (HCPC)Ìý

Additional outcomes:

To gain the level 7 qualification practitioners will need to demonstrate Master’s level critical appraisal during their studies, including the implications to their own practice.Ìý Nursing students who do not meet this outcome but demonstrate knowledge, skills and behaviours aligned to - and sufficient to pass - the level 6 module, may be able to transfer to PM4PP2.

Outline content:

This module will focus on supporting practitioners to apply a range of clinical and scientific knowledge to develop as prescribing practitioners.Ìý The content will also include consultation skills, prescribing in a team context, applied pharmacokinetics and pharmacodynamics, evidence-based practice, professional aspects to prescribing, and using information resources.

Workplace-based learning will begin to focus on the practitioner’s individual scope of practice, applying the taught content to their own context and patient population.

Global context:

As an accredited programme this module can only be offered to UK practising nurses and allied health professionals who meet the entry criteria.

Brief description of teaching and learning methods:

This module will use a range of teaching and learning methods.? The University teaching is based around face to face workshops using a mixture of presentations, problem-based learning and case-based learning, facilitated by the programme team, specialists and other healthcare professionals.? The workshops are underpinned by directed learning via Blackboard and self-directed learning where practitioners are required to use a range of sources to gain information to support developing their know ledge and skills.Ìý

There are no mandatory hours of supervised workplace-based learning required for this module, but practitioners are encouraged to undertake activities to develop their knowledge, skills and behaviours in the workplace.? This will be guided by the professional portfolio of learning.? This experiential learning will be individual to the practitioner’s workplace and scope of practice therefore the ratio of hours that are work-based learning and wide r independent reading will vary between practitioners.Ìý

This module is usually studied with PMMNP2, PMMAP1 or PMMAP2, although the two modules may be studied concurrently.? As a standalone module it is usually studied over two to three months, and there may be more than one cohort per year, therefore the distinction of hours by term is not possible.? The hours shown for autumn term below are spread over the entire module.Ìý

Contact hours:

Ìý	Autumn	Spring	Summer
Seminars	30
Work-based learning	12
Guided independent study:	Ìý	Ìý	Ìý
Ìý Ìý Wider reading (independent)	64
Ìý Ìý Wider reading (directed)	12
Ìý Ìý Exam revision/preparation	30
Ìý Ìý Preparation for seminars	12
Ìý Ìý Completion of formative assessment tasks	3
Ìý Ìý Essay preparation	30
Ìý Ìý Reflection	7
Ìý	Ìý	Ìý	Ìý
Total hours by term	200	0	0
Ìý	Ìý	Ìý	Ìý
Total hours for module	200

Summative Assessment Methods:

Method	Percentage
Written assignment including essay	100

Summative assessment- Examinations:

Summative assessment- Coursework and in-class tests:

• There are two multiple choice tests (1 numeracy and 1 pharmacology) that take place during the module, which will be marked on a pass/fail basis.


• Students will also have to complete a case study of approximately 3,000 words which will be submitted at the end of the module. The case study will be marked out of 100.

Formative assessment methods:

1. Workplace-based assessments during workplace-based learning


2. Feedback on workplace-based learning from supervisors


3. Feedback from programme team during workshops


4. Development of own personal formulary/medication profile in pharmacology workshops


5. Mock numeracy and pharmacology exam papers


6. Optional formative feedback on draft case study

Penalties for late submission:

The below information applies to students on taught programmes except those on Postgraduate Flexible programmes. Penalties for late submission, and the associated procedures, which apply to Postgraduate Flexible programmes are specified in the policy 'Penalties for late submission for Postgraduate Flexible programmes', which can be found here: /cqsd/-/media/project/functions/cqsd/documents/cqsd-old-site-documents/penaltiesforlatesubmissionpgflexible.pdf
The Support Centres will apply the following penalties for work submitted late:

• where the piece of work is submitted after the original deadline (or any formally agreed extension to the deadline): 10% of the total marks available for that piece of work will be deducted from the mark for each working day (or part thereof) following the deadline up to a total of five working days;
• where the piece of work is submitted more than five working days after the original deadline (or any formally agreed extension to the deadline): a mark of zero will be recorded.

The University policy statement on penalties for late submission can be found at: /cqsd/-/media/project/functions/cqsd/documents/cqsd-old-site-documents/penaltiesforlatesubmission.pdf
You are strongly advised to ensure that coursework is submitted by the relevant deadline. You should note that it is advisable to submit work in an unfinished state rather than to fail to submit any work.

Assessment requirements for a pass:

All elements of assessment must be passed; there is no compensation between elements:

1. The numeracy section of the exam paper must be passed at 100%


2. The pharmacology section of the exam paper must be passed at 80%


3. The case study must be passed at 50% with all essential criteria met

Reassessment arrangements:

Reassessment will usually be arranged promptly to allow for students to continue their studies although where necessary may occur with the next cohort, within a three to four-month period.Ìý Individualised timings may be required depending on the specific requirements for reassessment and ongoing further study.

Practitioners who fail one section of the exam paper but pass the other will only be required to resit the failed section. ÌýFor students who have passed all elements of the module except for the numeracy section of the exam paper, an exceptional third attempt is permitted for that section of the paper only.

Additional Costs (specified where applicable):

1) Required text books:Ìý

2) Specialist equipment or materials:Ìý

3) Specialist clothing, footwear or headgear:Ìý

4) Printing and binding:Ìý

5) Computers and devices with a particular specification:Ìý

6) Travel, accommodation and subsistence:Ìý

Last updated: 30 March 2023